Subsequent Events - Additional Information (Detail) (USD $)
|
12 Months Ended | 1 Months Ended | 0 Months Ended | 2 Months Ended | 0 Months Ended | ||
---|---|---|---|---|---|---|---|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Mar. 02, 2015
|
Jan. 14, 2015
|
Feb. 18, 2015
|
Mar. 10, 2015
|
|
Subsequent Event [Line Items] | |||||||
Interest Expense, Debt | $ 1,300,000us-gaap_InterestExpenseDebt | $ 1,900,000us-gaap_InterestExpenseDebt | $ 670,000us-gaap_InterestExpenseDebt | ||||
Subsequent Event [Member] | Private Placement [Member] | |||||||
Subsequent Event [Line Items] | |||||||
Interest Expense, Debt |
10,000,000us-gaap_InterestExpenseDebt / us-gaap_SubsequentEventTypeAxis = us-gaap_SubsequentEventMember / us-gaap_SubsidiarySaleOfStockAxis = us-gaap_PrivatePlacementMember |
||||||
Subsequent Event [Member] | Coronado SO Company [Member] | Licensing Agreements [Member] | |||||||
Subsequent Event [Line Items] | |||||||
Payments for Royalties |
900,000us-gaap_PaymentsForRoyalties / us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_LicensingAgreementsMember / dei_LegalEntityAxis = cndo_CoronadoSoCompanyMember / us-gaap_SubsequentEventTypeAxis = us-gaap_SubsequentEventMember |
||||||
Accrued Royalties, Current |
900,000us-gaap_AccruedRoyaltiesCurrent / us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_LicensingAgreementsMember / dei_LegalEntityAxis = cndo_CoronadoSoCompanyMember / us-gaap_SubsequentEventTypeAxis = us-gaap_SubsequentEventMember |
||||||
Subsequent Event [Member] | Revogenex Ireland Ltd [Member] | Licensing Agreements [Member] | |||||||
Subsequent Event [Line Items] | |||||||
Payments to Acquire Intangible Assets |
2,000,000us-gaap_PaymentsToAcquireIntangibleAssets / us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_LicensingAgreementsMember / dei_LegalEntityAxis = cndo_RevogenexIrelandLtdMember / us-gaap_SubsequentEventTypeAxis = us-gaap_SubsequentEventMember |
||||||
Subsequent Event [Member] | Journey Medical Corporation [Member] | |||||||
Subsequent Event [Line Items] | |||||||
Payments to Acquire Intangible Assets |
1,250,000us-gaap_PaymentsToAcquireIntangibleAssets / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = cndo_JourneyMedicalCorporationMember / us-gaap_SubsequentEventTypeAxis = us-gaap_SubsequentEventMember |
||||||
License Costs |
$ 750,000us-gaap_LicenseCosts / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = cndo_JourneyMedicalCorporationMember / us-gaap_SubsequentEventTypeAxis = us-gaap_SubsequentEventMember |
X | ||||||||||
- Definition
Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of the cost of borrowed funds accounted for as interest expense for debt. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Costs incurred and are directly related to generating license revenue. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of cash paid for royalties during the current period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|